Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial. - Sun F; Wang H; Zhang D; Shen N; Chen S; Li T; Wan W; Dai SM; Ye S (Annals of the rheumatic diseases, 2026)